Case Report
Published on 09 Oct 2025
Case Report: Fluzoparib combined Exemestane in gBRCA2-mutated HR+/HER2− advanced breast cancer
in Pharmacology of Anti-Cancer Drugs
- 248 views
Case Report
Published on 09 Oct 2025
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 09 Oct 2025
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 09 Oct 2025
in Oral and Maxillofacial Surgery
Original Research
Published on 09 Oct 2025
in Personality Disorders
Original Research
Published on 09 Oct 2025
in Human-Media Interaction
Case Report
Published on 09 Oct 2025
in Radiation Oncology
Original Research
Published on 09 Oct 2025
in Neurocognitive Aging and Behavior
Original Research
Published on 09 Oct 2025
in Public Mental Health
Original Research
Published on 09 Oct 2025
in Bone Research
Original Research
Published on 09 Oct 2025
in Plant Bioinformatics
Case Report
Published on 09 Oct 2025
in Pulmonary Medicine
Original Research
Published on 09 Oct 2025
in Health Psychology
Original Research
Published on 09 Oct 2025
in Ophthalmology
Original Research
Published on 09 Oct 2025
in Food Chemistry
Original Research
Published on 09 Oct 2025
in Occupational Health and Safety
Original Research
Published on 09 Oct 2025
in Translational Pharmacology